# Abbott Laboratories (ABT) stock: price and valuation

URL: https://funkfolio.com/stock/ABT

> Abbott Laboratories (ABT) trades at $105.29, is worth $182.36B, is priced at 39.3× earnings and scores 58/100. Valuation, financials and signals.

---

## Abbott Laboratories (ABT)

Abbott Laboratories (ABT) is a healthcare company (medical devices) based in the United States. The share price is $105.29, down 2.01% on the day, which values the company at $182.36B. Price as of 17 Nov 2026, 19:04 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $105.29 −2.01% today
- **Market value:** $182.36B
- **P/E ratio:** 39.3× last 12 months
- **Forward P/E:** 17.7×
- **Dividend yield:** 2.35%
- **Funk Score:** 58/100
- **Against its own history:** About its usual price usual price $98.97
- **200-week average:** $112.40 6% below

Figures as of 17 Nov 2026, 19:04 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Abbott Laboratories in more detail

ABT trades at 39.3× its last twelve months' earnings, 17.7× next year's expected earnings, 3.8× sales. Measured against its own history, the price is 6% above what its usual multiples would imply ($98.97) — about its usual price. It sits 6% below its 200-week average of $112.40.

Over the last five fiscal years Abbott Laboratories has compounded revenue 5.1% a year, earnings per share 8.3% a year, free cash flow 5.3% a year. Its Funk Score is 58 out of 100 (financial strength 8.1, profitability 6.3, growth 4.2, value 4.8, each out of 10).

In its favour: Altman Z in the safe zone.

15 of the superinvestors tracked here hold ABT, including Mason Hawkins (4.0% of the portfolio), Jensen team (2.4% of the portfolio), Diamond Hill team (2.2% of the portfolio).

### Superinvestors holding ABT

15 of the investors tracked here report a position in their latest 13F filing.

- [Mason Hawkins Southeastern Asset Management (Longleaf)](https://funkfolio.com/gurus/mason-hawkins) 3.98% of portfolio · $76.3M · new · Q2 2026
- [Jensen team Jensen Investment Management](https://funkfolio.com/gurus/jensen-investment) 2.38% of portfolio · $75.8M · trimmed · Q3 2026
- [Diamond Hill team Diamond Hill Capital Management](https://funkfolio.com/gurus/diamond-hill) 2.19% of portfolio · $200.8M · trimmed · Q3 2026
- [Jeremy Grantham (co-founder) GMO (Grantham, Mayo, Van Otterloo)](https://funkfolio.com/gurus/jeremy-grantham) 1.90% of portfolio · $886.2M · added · Q3 2026
- [Mairs & Power team Mairs & Power](https://funkfolio.com/gurus/mairs-and-power) 0.67% of portfolio · $72.7M · added · Q3 2026
- [Brandon Haley Holocene Advisors](https://funkfolio.com/gurus/brandon-haley) 0.52% of portfolio · $226M · added · Q2 2026
- [Ken Griffin Citadel Advisors](https://funkfolio.com/gurus/ken-griffin) 0.45% of portfolio · $780.1M · added · Q2 2026
- [John Overdeck and David Siegel (founders) Two Sigma Investments](https://funkfolio.com/gurus/two-sigma) 0.36% of portfolio · $494.7M · trimmed · Q3 2026
- [Paul Tudor Jones Tudor Investment Corp](https://funkfolio.com/gurus/paul-tudor-jones) 0.27% of portfolio · $66.3M · added · Q2 2026
- [Israel Englander Millennium Management](https://funkfolio.com/gurus/israel-englander) 0.22% of portfolio · $326.7M · added · Q2 2026
- [Steve Cohen Point72 Asset Management](https://funkfolio.com/gurus/steve-cohen) 0.22% of portfolio · $140.8M · new · Q2 2026
- [Lew Sanders Sanders Capital](https://funkfolio.com/gurus/lew-sanders) 0.10% of portfolio · $99.3M · trimmed · Q3 2026
- [George Soros Soros Fund Management](https://funkfolio.com/gurus/george-soros) 0.07% of portfolio · $4.4M · Q3 2026
- [Thomas Russo Gardner Russo & Quinn](https://funkfolio.com/gurus/thomas-russo) 0.01% of portfolio · $1.1M · Q3 2026
- [Howard Gleicher Aristotle Capital Management](https://funkfolio.com/gurus/howard-gleicher) 0.01% of portfolio · $5.2M · trimmed · Q3 2026

### Health Care companies of similar size

- [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH)
- [Novartis NVS](https://funkfolio.com/stock/NVS)
- [AstraZeneca AZN](https://funkfolio.com/stock/AZN)
- [Thermo Fisher Scientific TMO](https://funkfolio.com/stock/TMO)
- [Amgen AMGN](https://funkfolio.com/stock/AMGN)
- [Gilead Sciences GILD](https://funkfolio.com/stock/GILD)
- [Novo Nordisk NVO](https://funkfolio.com/stock/NVO)
- [Pfizer PFE](https://funkfolio.com/stock/PFE)
- [Danaher DHR](https://funkfolio.com/stock/DHR)
- [Intuitive Surgical ISRG](https://funkfolio.com/stock/ISRG)
- [Vertex Pharmaceuticals VRTX](https://funkfolio.com/stock/VRTX)
- [Medtronic MDT](https://funkfolio.com/stock/MDT)

Side by side: [ABT vs NVO (Abbott Laboratories vs Novo Nordisk)](https://funkfolio.com/compare/abt-vs-nvo) [ABT vs GILD (Abbott Laboratories vs Gilead Sciences)](https://funkfolio.com/compare/abt-vs-gild) [ABT vs PFE (Abbott Laboratories vs Pfizer)](https://funkfolio.com/compare/abt-vs-pfe) [ABT vs DHR (Abbott Laboratories vs Danaher)](https://funkfolio.com/compare/abt-vs-dhr) [ABT vs ISRG (Abbott Laboratories vs Intuitive Surgical)](https://funkfolio.com/compare/abt-vs-isrg)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Abbott Laboratories (ABT): questions and answers

**What is ABT's P/E ratio?**

Abbott Laboratories trades at 39.3× its last twelve months' earnings and 17.7× next year's expected earnings. At its fiscal year-ends over the past 19 years the P/E ranged from 7.8× to 211.4×, with a median of 28.1×.

**What is ABT's PEG ratio?**

Abbott Laboratories's PEG ratio is 1.55 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Abbott Laboratories's market cap?**

Abbott Laboratories is valued at $182.36B at a share price of $105.29.

**Is ABT overvalued or undervalued?**

Against its own history, ABT is about its usual price: the price is 6% above the $98.97 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is ABT above its 200-week moving average?**

No. ABT is 6.3% below its 200-week average of $112.40. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Abbott Laboratories growing?**

Over the last five fiscal years Abbott Laboratories's revenue grew 5.1% a year and its earnings per share 8.3% a year; over ten years revenue grew 8.1% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Abbott Laboratories (ABT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ABT

Underlying data: Yahoo Finance; company filings with the SEC.
